PhD-level clinical scientist with 10+ years of expertise in CNS neurodegeneration (Parkinson’s disease, Alzheimer’s disease, synucleinopathies, tauopathies, iRBD), seeking a senior medical affairs role. Four core strengths: (1) deep therapeutic expertise across CNS clinical research and biomarker development; (2) hands-on Health Canada-regulated clinical trial execution and regulatory documentation; (3) established credibility with international KOLs and clinical stakeholders, with 15+ congress presentations and invited lectures at Columbia, Karolinska, and Universidad Complutense de Madrid; (4) excellence in scientific communication across 50 peer-reviewed publications and over 100 manuscript reviews to date for leading neurology and movement disorders journals.